Emcure Pharmaceuticals Ltd, an Indian pharmaceutical company focused on women’s health, has expanded its over-the-counter (OTC) portfolio with the Arth supplement range. The company has introduced three new products to address intimate care, sleep quality, and cognitive health.
The expansion is an entry into the daily wellness segment, combining traditional Indian herbs like Brahmi with modern scientific formulations, as per the filing.
The newly introduced supplements under the Arth brand include:
To amplify awareness around women’s health, Emcure has partnered with Vidya Balan, for the same. On joining hands with Emcure, Balan expressed her enthusiasm for the brand’s mission. She talked about how women’s health often takes a backseat despite their crucial role in families and society. She hopes that her association will encourage women to prioritize self-care through informed choices.
Emcure Pharmaceuticals, founded in 1981 and headquartered in Pune, is ranked as the 12th largest pharmaceutical company in India based on domestic sales (MAT June 2024). The company operates in over 70 countries, including Europe and Canada, with a focus on R&D-driven pharmaceutical development. The launch of the Arth range is an expansion into the non-prescription wellness segment.
As of March 11, 2025, 09:30 AM, Emcure Pharmaceuticals Ltd was trading at ₹942.80, showing a 0.28% increase (+₹2.60). The stock has recorded a 15.12% decline over the past month and a 33.99% drop in the last six months.
The launch of Arth supplements broadens Emcure’s product portfolio beyond prescription drugs. The company is expanding its OTC offerings, focusing on science-backed health solutions in the wellness market.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Mar 11, 2025, 2:45 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates